544 related articles for article (PubMed ID: 15645531)
1. FP-CIT and MIBG scintigraphy in early Parkinson's disease.
Spiegel J; Möllers MO; Jost WH; Fuss G; Samnick S; Dillmann U; Becker G; Kirsch CM
Mov Disord; 2005 May; 20(5):552-61. PubMed ID: 15645531
[TBL] [Abstract][Full Text] [Related]
2. Cardiac 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD.
Saiki S; Hirose G; Sakai K; Kataoka S; Hori A; Saiki M; Kaito M; Higashi K; Taki S; Kakeshita K; Fujino S; Miaki M
J Neurol Sci; 2004 May; 220(1-2):105-11. PubMed ID: 15140615
[TBL] [Abstract][Full Text] [Related]
3. Imaging of dopamine transporters with [123I]FP-CIT SPECT does not suggest a significant effect of age on the symptomatic threshold of disease in Parkinson's disease.
Booij J; Bergmans P; Winogrodzka A; Speelman JD; Wolters EC
Synapse; 2001 Feb; 39(2):101-8. PubMed ID: 11180497
[TBL] [Abstract][Full Text] [Related]
4. Different patterns of nigrostriatal degeneration in tremor type versus the akinetic-rigid and mixed types of Parkinson's disease at the early stages: molecular imaging with 123I-FP-CIT SPECT.
Schillaci O; Chiaravalloti A; Pierantozzi M; Di Pietro B; Koch G; Bruni C; Stanzione P; Stefani A
Int J Mol Med; 2011 Nov; 28(5):881-6. PubMed ID: 21811760
[TBL] [Abstract][Full Text] [Related]
5. [Diagnostic value of cardiac 123I-metaiodobenzylguanidine (123I-MIBG) scintigraphy in Lewy body disorders].
Escamilla-Sevilla F; Pérez-Navarro MJ; Muñoz-Pasadas M; Ortega-Léon T; Gallego-Peinado M; Cabello-García D; Gómez Río M; Ortega-Moreno A; Carnero-Pardo C; Rebollo-Aguirre AC; Mínguez-Castellanos A
Neurologia; 2009 Apr; 24(3):170-6. PubMed ID: 19418293
[TBL] [Abstract][Full Text] [Related]
6. Cardiac sympathetic impairment parallels nigrostriatal degeneration in Probable Dementia with Lewy Bodies.
Camacho V; Marquié M; Lleó A; Alvés L; Artigas C; Flotats A; Duch J; Blesa R; Gómez-Isla T; Carrió I; Estorch M
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):476-83. PubMed ID: 21150861
[TBL] [Abstract][Full Text] [Related]
7. 123I-FP-CIT brain SPECT (DaTSCAN) imaging in the diagnosis of patients with movement disorders--first results.
Jauković L; Ilić TV; Dopudja M; Ajdinović B
Vojnosanit Pregl; 2012 Feb; 69(2):157-62. PubMed ID: 22500370
[TBL] [Abstract][Full Text] [Related]
8. 123I-MIBG cardiac uptake, smell identification and 123I-FP-CIT SPECT in the differential diagnosis between vascular parkinsonism and Parkinson's disease.
Navarro-Otano J; Gaig C; Muxi A; Lomeña F; Compta Y; Buongiorno MT; Martí MJ; Tolosa E; Valldeoriola F
Parkinsonism Relat Disord; 2014 Feb; 20(2):192-7. PubMed ID: 24252299
[TBL] [Abstract][Full Text] [Related]
9. Cardiac ¹²³I-MIBG scintigraphy as an outcome-predicting tool for subthalamic nucleus stimulation in Parkinson's disease.
Yamada K; Shiraishi SY; Hamasaki T; Kuratsu J
Acta Neurochir (Wien); 2010 Dec; 152(12):2063-8. PubMed ID: 20927559
[TBL] [Abstract][Full Text] [Related]
10. Clinical impact of correlative [123I]-FP-CIT brain imaging and neurological findings in suspect Parkinson's disease.
Covelli EM; Brunetti A; Di Lauro A; Sullo P; Mazzarella G; Tedeschi E; Belfiore G
Radiol Med; 2004 Oct; 108(4):417-25. PubMed ID: 15525895
[TBL] [Abstract][Full Text] [Related]
11. Iodine-123-N-omega-fluoropropyl-2beta-carbomethoxy-3beta-(4-iod ophenyl)tropane SPECT in healthy controls and early-stage, drug-naive Parkinson's disease.
Tissingh G; Booij J; Bergmans P; Winogrodzka A; Janssen AG; van Royen EA; Stoof JC; Wolters EC
J Nucl Med; 1998 Jul; 39(7):1143-8. PubMed ID: 9669384
[TBL] [Abstract][Full Text] [Related]
12. Investigating dopaminergic neurotransmission with 123I-FP-CIT SPECT: comparability of modern SPECT systems.
Meyer PT; Sattler B; Lincke T; Seese A; Sabri O
J Nucl Med; 2003 May; 44(5):839-45. PubMed ID: 12732687
[TBL] [Abstract][Full Text] [Related]
13. 123I-FP-CIT semi-quantitative SPECT detects preclinical bilateral dopaminergic deficit in early Parkinson's disease with unilateral symptoms.
Filippi L; Manni C; Pierantozzi M; Brusa L; Danieli R; Stanzione P; Schillaci O
Nucl Med Commun; 2005 May; 26(5):421-6. PubMed ID: 15838424
[TBL] [Abstract][Full Text] [Related]
14. Combined use of dopamine transporter imaging (DAT-SPECT) and
Yoshii F; Ryo M; Baba Y; Koide T; Hashimoto J
J Neurol Sci; 2017 Apr; 375():80-85. PubMed ID: 28320195
[TBL] [Abstract][Full Text] [Related]
15. Progressive Olfactory Impairment and Cardiac Sympathetic Denervation in REM Sleep Behavior Disorder.
Janzen A; Vadasz D; Booij J; Luster M; Librizzi D; Henrich MT; Timmermann L; Habibi M; Sittig E; Mayer G; Geibl F; Oertel W
J Parkinsons Dis; 2022; 12(6):1921-1935. PubMed ID: 35754288
[TBL] [Abstract][Full Text] [Related]
16. [Cardiac sympathetic dysfunction in Parkinson's disease--relationship between results of 123I-MIBG scintigraphy and autonomic nervous function evaluated by the Valsalva maneuver].
Oka H; Yoshioka M; Morita M; Mochio S; Inoue K
Rinsho Shinkeigaku; 2003 Aug; 43(8):465-9. PubMed ID: 14658397
[TBL] [Abstract][Full Text] [Related]
17. Chronic motor cortex stimulation in patients with advanced Parkinson's disease and effects on striatal dopaminergic transmission as assessed by 123I-FP-CIT SPECT: a preliminary report.
Di Giuda D; Calcagni ML; Totaro M; Cocciolillo F; Piano C; Soleti F; Fasano A; Cioni B; Bentivoglio AR; Giordano A
Nucl Med Commun; 2012 Sep; 33(9):933-40. PubMed ID: 22735298
[TBL] [Abstract][Full Text] [Related]
18. The utility of the combination of a SPECT study with [123I]-FP-CIT of dopamine transporters and [123I]-MIBG myocardial scintigraphy in differentiating Parkinson disease from other degenerative parkinsonian syndromes.
Uyama N; Otsuka H; Shinya T; Otomi Y; Harada M; Sako W; Izumi Y; Kaji R; Watanabe Y; Takashi S; Kunikane Y
Nucl Med Commun; 2017 Jun; 38(6):487-492. PubMed ID: 28410288
[TBL] [Abstract][Full Text] [Related]
19. Precise Evaluation of Striatal Oxidative Stress Corrected for Severity of Dopaminergic Neuronal Degeneration in Patients with Parkinson's Disease: A Study with 62Cu-ATSM PET and 123I-FP-CIT SPECT.
Neishi H; Ikawa M; Okazawa H; Tsujikawa T; Arishima H; Kikuta KI; Yoneda M
Eur Neurol; 2017; 78(3-4):161-168. PubMed ID: 28848099
[TBL] [Abstract][Full Text] [Related]
20. Correlation with sympathetic skin response,
Ozawa M; Morishima R; Shimizu T; Takahashi K
Neurophysiol Clin; 2024 Jul; 54(4):102956. PubMed ID: 38422587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
